MARKET

OTLC

OTLC

Oncotelic Therapeutics Inc
OTCMQB
0.091
+0.001
+0.67%
Closed 13:39 12/04 EST
OPEN
0.092
PREV CLOSE
0.090
HIGH
0.092
LOW
0.091
VOLUME
30.00K
TURNOVER
2.75K
52 WEEK HIGH
0.108
52 WEEK LOW
0.025
MARKET CAP
39.93M
P/E (TTM)
-22.0976
1D
5D
1M
3M
1Y
5Y
1D
ONCOTELIC AND SAPU NANO ANNOUNCES NEW PK DATA DEMONSTRATING IV SAPU003 REDUCES GI ACCUMULATION OF EVEROLIMUS UP TO 67-FOLD COMPARED WITH ORAL DOSING
Reuters · 1d ago
Weekly Report: what happened at OTLC last week (1124-1128)?
Weekly Report · 4d ago
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation
Barchart · 11/25 07:30
Weekly Report: what happened at OTLC last week (1117-1121)?
Weekly Report · 11/24 09:11
ONCOTELIC THERAPEUTICS INC. (OTCQB: OTLC) EMERGING AS LEADER WITH NEW INDEPENDENT JV VALUATION
Reuters · 11/21 13:30
ONCOTELIC THERAPEUTICS - JV IS PREPARING FOR A POTENTIAL INITIAL PUBLIC OFFERING ON THE HONG KONG STOCK EXCHANGE IN LATE 2026
Reuters · 11/20 12:56
Oncotelic Achieves Breakthrough $1.7 Billion Pipeline Valuation Through GMP Bio Joint Venture
Barchart · 11/20 06:55
Weekly Report: what happened at OTLC last week (1110-1114)?
Weekly Report · 11/17 09:11
More
About OTLC
Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for the treatment of orphan oncology indications, developing antisense and small-molecule injectable drugs for the treatment of cancer. The Company has three primary drugs and AI technology programs: AL-101 - Intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of Parkinson’s Disease (PD), erectile dysfunction (ED) and female sexual dysfunction (FSD); CA4P- a vascular disrupting agent (VDA) - in combination with Ipilimumab for the treatment of solid tumors with focus on melanoma in adult and pediatric melanoma; Oxi4503- a second generation VDA - for the treatment of liquid tumors with focus on childhood leukemia; OT-101 - an antisense against TGF-b2-for the treatment of various cancers and for the treatment of various viruses, and Artemisinin-a natural derivative from an Asian herb Artemisia Annua.

Webull offers Oncotelic Therapeutics Inc stock information, including OTCMQB: OTLC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OTLC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OTLC stock methods without spending real money on the virtual paper trading platform.